Eupraxia Pharmaceuticals Inc. (000044103)

Profile details

Profile number
000044103
Status
Public
Full legal company name in English
Eupraxia Pharmaceuticals Inc.
Full legal company name in French
Eupraxia Pharmaceuticals Inc.
Effective from date
11 May 2012
This company is an Investment Fund Manager
No
This company is an Underwriter
No
Head office address
2198 Yukon Street, Vancouver, British Columbia, V5Y 3P1, Canada
Mailing address
Same as head office
Fax number
 

Company identification

Legal Entity Identifier (LEI)
 

Reporting issuer details

Reporting issuer
Yes
Over-The-Counter (OTC) issuer
No
Exchangeable Security or Credit Support issuer
Not applicable
Capital Pool Company (CPC)
No
Eligible for short form prospectus
Yes
Principal jurisdiction
British Columbia
Reporting jurisdiction(s)
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Prince Edward Island, Saskatchewan

Formation details

Date of formation
12 May 2011
Manner of formation
Corporation
Jurisdiction where formed
Canada, British Columbia
Chief Executive Officer (CEO) - full legal name
HELLIWELL, James Allen
Chief Financial Officer (CFO) - full legal name
COUSINS, Bruce Gordon

Financial year end

Type of financial year end
Fixed year end
Financial year end
December 31

Size and industry classification

NAICS
000000 - NAICS Unknown
Size of issuer (assets)
$25 million to under $100 million

Securities

Listed on an exchange or other market place
Yes
Exchange or market place
Toronto Stock Exchange (TSX) - EPRX
CUSIP
29842P
ISIN
CA29842P1053

Associated entities

Transfer agent or registrar
No
Auditor
KPMG LLP / KPMG LLP
Address
777 Dunsmuir Street, 11th Floor, Vancouver, British Columbia, V7Y 1K3, Canada

Previous issuers

Previous issuer(s)
No
Unsaved changes will be lost. Are you sure you wish to exit?
Unsaved changes will be lost. Are you sure you want to cancel?
???label.checkSubmitMsg???